|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|
| Deferred offering costs | ||||||||
| Current Assets | ||||||||
| Cash | ||||||||
| Prepaid expenses | ||||||||
| Total Current Assets | ||||||||
| Prepaid expenses – long term | ||||||||
| Investments held in Trust Account | ||||||||
| TOTAL ASSETS | ||||||||
| Current liabilities | ||||||||
| Accrued expenses | ||||||||
| Accrued offering costs | ||||||||
| Promissory note – related party | ||||||||
| Total Current Liabilities | ||||||||
| Deferred underwriting fee payable | ||||||||
| Total Liabilities | ||||||||
| Class A ordinary shares subject to possible redemption; 17,250,000 shares at $10.14 and $10.00 per share redemption value at December 31, 2022 and 2021, respectively | ||||||||
| Shareholders’ Deficit | ||||||||
| Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 545,000 issued and outstanding (excluding 17,250,000 Class A ordinary shares subject to possible redemption) as of December 31, 2022 and 2021 | ||||||||
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 2,300,000 shares issued and outstanding as of December 31, 2022 and 2021 | ||||||||
| Class F ordinary shares, $0.0001 par value, 50,000,000 shares authorized; 3,450,000 shares issued and outstanding as of December 31, 2022 and 2021 | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Total Shareholders’ Deficit | ||||||||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT |
Loading...
